| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-221 | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-221 | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-222 | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-222 | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-22 | Paclitaxel | colon cancer | Sensitive | Low | 21594648 | |
| miR-22 | Paclitaxel | ovarian cancer | Sensitive | High | 23627607 | |
| miR-221 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-2277 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-2278 | Paclitaxel | laryngeal cancer | Sensitive | High | 23826416 | |
| miR-223 | Paclitaxel | hepatocellular carcinoma | Sensitive | Low | 23925649 | |
| miR-223 | Paclitaxel | breast cancer | Sensitive | Low | 24400121 | |
| miR-224 | Paclitaxel | gastric cancer | Sensitive | High | 24817940 | |
| miR-224* | Paclitaxel | gastric cancer | Sensitive | High | 24817940 | |
| miR-22 | Paclitaxel | nasopharyngeal carcinoma | Resistant | High | 25400759 | |
| miR-22 | Paclitaxel | nasopharyngeal carcinoma | Resistant | High | 25756509 | |
| miR-224 | Paclitaxel | cervical cancer | Sensitive | Low | 26390698 |